All blog posts
Showing 180 out of 216 results
Patent and Pharma Update - December 2018
Italy moves the unitary patent a step closer
CJEU rules on whether the NHS reimbursing off-label medicinal products for cost-cutting purposes conflicts with Directive 2001/83/EC
Novartis Farma S.p.A. v Italian Medicines Agency and Roche Italia S.p.A. On 21 November 2018, the CJEU issued an important decision in Novartis Farma v …
French court upholds validity of MSD's SPC protecting ezetimibe and simvastatin in combination
A French Court has upheld the validity of a Supplementary Protection Certificate ("SPC") protecting the ezetimibe+simvastatin combination under Article …
Draft Withdrawal Agreement Approved by UK Cabinet - IP and Marketing Authorisation Provisions Summarised
As was widely reported yesterday evening, the Draft Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the …
UK SUPREME COURT RAISES SUFFICIENCY STANDARD FOR SWISS-FORM CLAIMS AND LIMITS THE ABILITY TO ASSERT THEM AGAINST "SKINNY LABEL" PRODUCTS
Commercial impact Yesterday's Supreme Court decision in Warner-Lambert v Mylan is disappointing news for patentees who may have made significant …
France adopts a confidentiality regime for the trade secrets relied upon in (patent) litigation
As part of the French Law on the Protection of Trade Secrets dated 31 July 2018, French lawmakers have finally adopted a long-awaited array of …
Patent and Pharma Update - October 2018
Key recent developments in the United Kingdom and Europe relating to patents and the pharmaceutical sector The CJEU has provided its preliminary ruling …
EPO publishes 2018 revision of Guidelines for Examination directed to computer-implemented inventions
The EPO has recently published the 2018 revision to its Guidelines for Examination, which are generally updated annually to take into account …
UK Government launches consultation on role of MHRA post-Brexit and confirms commitment to underwrite Horizon 2020 funding
The UK Government has today launched a consultation on the role of the Medicines and Healthcare products Regulatory Agency (MHRA) post-Brexit "seeking …
Brexit "no deal" technical notices published on Patents, Trade marks, Designs, Copyright, GIs, and Exhaustion of rights
The latest tranche of "no deal" technical notices was released yesterday afternoon by the UK Government. Amongst them are several notices …
Brexit "No Deal" Technical Notices - lots for the life sciences sector to think about
The UK Government issued the first batch of its Brexit "No Deal" Technical Notices on 23 August 2018. These are designed to provide guidance to …
Showing 180 out of 216 results
View more